Dermatology biotech Arcutis Biotherapeutics sets terms for $125 million IPO - (NASDAQ via NewsPoints Desk)

  • Arcutis Biotherapeutics announced plans to raise $125 million by offering 7.8 million shares at a price range of $15 to $17, reported NASDAQ.

  • The Phase III biotechnology company is developing topical therapies for common skin diseases.

To read more NewsPoints articles, click here.